Medical Imaging Department, Mater Dei Hospital, Msida, Malta.
Radiology Institute, Department of Medicine - DIMED, University of Padua, Padova, Italy.
Radiol Med. 2021 Nov;126(11):1487-1495. doi: 10.1007/s11547-021-01404-1. Epub 2021 Aug 18.
Transjugular portal vein puncture is considered the riskiest step in TIPS creation with possible incidence of portal vein puncture-related complications (PVPC). The Colapinto and the Rösch-Uchida needle sets are two different needle sets currently available. To date, there have been no randomized control trials or systematic reviews which compare the incidence of PVPC when using the two different needle sets. The aim of this literature review is to assess the rate of PVPC associated with the different needle sets used in the creation of TIPS. From the described search, 1500 articles were identified and 34 met the inclusion criteria. Outcome measured was the prevalence of PVPC using the different needle sets. Overall 212 (3.6%) PVPC were reported in 5865 patients; 142 (3.5%) reported in 4000 cases using the Rösch-Uchida set and 70 (3.7%) in 1865 patients using the Colapinto set (p = 0.69). PVPC in TIPS creation are not related to the choice of needle set used in the procedure. To our knowledge, this is the first review of its kind, the results of which support the theory that while the rate of PVPC is influenced by many factors, choice of needle set does not seem to be one of them.
经颈静脉肝内门体分流术（TIPS）创建过程中，经颈静脉肝内穿刺门静脉（Transjugular portal vein puncture）被认为是风险最高的步骤，可能会发生与门静脉穿刺相关的并发症（portal vein puncture-related complications，PVPC）。目前有两种不同的穿刺套件，即 Colapinto 套件和 Rösch-Uchida 套件。迄今为止，尚无比较两种不同穿刺套件使用时发生 PVPC 发生率的随机对照试验或系统评价。本文献复习的目的是评估使用不同穿刺套件进行 TIPS 创建时与 PVPC 相关的发生率。通过描述性搜索，共确定了 1500 篇文章，其中 34 篇符合纳入标准。测量的结果是使用不同穿刺套件发生 PVPC 的患病率。总体而言，在 5865 例患者中报告了 212 例（3.6%）PVPC；在使用 Rösch-Uchida 套件的 4000 例患者中有 142 例（3.5%），在使用 Colapinto 套件的 1865 例患者中有 70 例（3.7%）（p=0.69）。TIPS 治疗中发生的 PVPC 与用于该程序的穿刺套件的选择无关。据我们所知，这是首例此类综述，其结果支持这样一种理论，即尽管 PVPC 的发生率受到许多因素的影响，但穿刺套件的选择似乎不是其中之一。
